Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

The association between infliximab (IFX) and fecal calprotectin (FC) levels on one hand, and the clinical and endoscopic response of patients with inflammatory bowel disease on the other, is well established. To investigate the association between inflammatory biochemical parameters and serum concen...

Full description

Saved in:

Bibliographic Details
Published in:	Digestive diseases (Basel) Vol. 37; no. 2; p. 108
Main Authors:	Beltrán, Belén, Iborra, Marisa, Sáez-González, Esteban, Marqués-Miñana, Maria R, Moret, Inés, Cerrillo, Elena, Tortosa, Luis, Bastida, Guillermo, Hinojosa, Joaquín, Poveda-Andrés, Jose Luis, Nos, Pilar
Format:	Journal Article
Language:	English
Published:	Switzerland 2019
Subjects:	Adolescent Adult Aged Crohn Disease - drug therapy Crohn Disease - metabolism Feces - chemistry Female Gastrointestinal Agents - therapeutic use Humans Infliximab - therapeutic use Leukocyte L1 Antigen Complex - metabolism Male Middle Aged Multivariate Analysis Prospective Studies Treatment Outcome Young Adult Fecal calprotectin Inflammatory bowel disease Primary nonresponse Trough levels Infliximab Crohn’s disease
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!